Atriumpharm, UAB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2024 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 2025 |
|---|
| 29,808 |
| 24,635 |
| 20,429 |
| 20,429 |
| 16,883 |
| 96.03 |
| 68.54 |
| 30,429 |
| 2,938 |
| 0 |
| 24,773 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 29,808 |
| 24,635 |
| 20,429 |
| 20,429 |
| 16,883 |
| 96.03 |
| 68.54 |
| 30,429 |
| 2,938 |
| 0 |
| 24,773 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
29,808 €- *
Sales per employee (€)
24,635 €- *
Profit before tax (€)
20,429 €- *
Net Profit (€)
20,429 €- *
Profit per employee (€)
16,883 €- *
Total profitability (%)
96.03 %- *
Net profitability (%)
68.54 %- *
Equity (€)
30,429 €- *
Amounts Payable And Liabilities (€)
2,938 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
24,773 €- *
